NCT04991805 2025-04-25Descriptive Study of the Incidence of Malignancy in Severe Asthma Patients Receiving Benralizumab and Other Biologic Therapy, a Post Authorization Safety StudyAstraZenecaCompleted14,000 enrolled
NCT06528418 2025-03-26Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled BreathChromX HealthRecruiting10,000 enrolled